Remote Patient Monitoring for Hypertension: Differentiating White Coat Syndrome
Clinical Risk: Why Untreated White Coat Hypertension Increases Cardiovascular Events by 36%
Regulatory Shifts: Leveraging CPT 99445 for Short-Term Diagnostic RPM
Home Blood Pressure Monitoring Accuracy in Vulnerable Populations
Choosing the Right Technology: Cellular-First Strategies for Hypertensive Panels
Sources
- Centers for Medicare and Medicaid Services (CMS). (2025). Remote Patient Monitoring Billing Guidelines and Updates.
- Den Hond, E., Celis, H., Vandenhoven, G., O’Brien, E., & Staessen, J. A. (2003). Determinants of white coat syndrome assessed by ambulatory blood pressure or self measured home blood pressure. Blood Pressure Monitoring, 8(1), 37 to 40.
- Franklin, S. S., Thijs, L., Asayama, K., Li, Y., Hansen, T. W., Boggia, J., Jacobs, L., & IDACO Investigators. (2016). The cardiovascular risk of white coat hypertension. JACC, 68(19).
- Franklin, S. S., Thijs, L., Hansen, T. W., O’Brien, E., & Staessen, J. A. (2013). White Coat Hypertension: New Insights From Recent Studies. Hypertension, 62(6). https://doi.org/10.1161/HYPERTENSIONAHA.113.01275
- Whelton, P. K., Carey, R. M., Aronow, W. S., et al. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), e13 to e115.